obesity drug news today glp-1 september 29 2025 New oral drugs could offer more options for weight loss GLP-1 receptor agonists and next-generation

Since our inception, we have devoted substantially all of our resources to raising capital, organizing and staffing our company, business and scientific planning, conducting discovery and research and development activities, establishing, maintaining, and protecting our intellectual property portfolio, developing and progressing our product candidates and preparing for clinical trials, establishing arrangements with third parties for the manufacture of our product candidates and component materials, engaging in collaboration activities, and providing general and administrative support for these operations

While beneficial, peptide therapy isnt for everyone

reduction in heart failure

Eight more chances to be present for the people and moments that matter

doi: 10.1073/pnas.0900914106

Mistake: expecting instant results Copper peptides work through biological processes that take time